These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31165524)

  • 21. Practicality of non-invasive glucagon-loaded dissolving microneedle for life-saving treatment of severe hypoglycemia in a diabetic rat model.
    Wang X; Ma Y; Qi X; Ruan X; Cao D; Zhao F
    Int J Pharm; 2023 Sep; 644():123340. PubMed ID: 37625601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Touch-actuated microneedle array patch for closed-loop transdermal drug delivery.
    Yang J; Chen Z; Ye R; Li J; Lin Y; Gao J; Ren L; Liu B; Jiang L
    Drug Deliv; 2018 Nov; 25(1):1728-1739. PubMed ID: 30182757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shrinking Fabrication of a Glucose-Responsive Glucagon Microneedle Patch.
    Wang Z; Fu R; Han X; Wen D; Wu Y; Li S; Gu Z
    Adv Sci (Weinh); 2022 Oct; 9(28):e2203274. PubMed ID: 35957510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-Responsive Insulin Delivery by Microneedle-Array Patches Loaded with Hypoxia-Sensitive Vesicles.
    Yu J; Zhang Y; Gu Z
    Methods Mol Biol; 2017; 1570():251-259. PubMed ID: 28238142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery.
    Wang J; Ye Y; Yu J; Kahkoska AR; Zhang X; Wang C; Sun W; Corder RD; Chen Z; Khan SA; Buse JB; Gu Z
    ACS Nano; 2018 Mar; 12(3):2466-2473. PubMed ID: 29455516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous glucagon in a deliberate insulin overdose in an adolescent with type 1 diabetes mellitus.
    White M; Zacharin MR; Werther GA; Cameron FJ
    Pediatr Diabetes; 2016 Feb; 17(1):66-9. PubMed ID: 25229989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H
    Hu X; Yu J; Qian C; Lu Y; Kahkoska AR; Xie Z; Jing X; Buse JB; Gu Z
    ACS Nano; 2017 Jan; 11(1):613-620. PubMed ID: 28051306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Evaluation of Glucagon Injection Anxiety and Its Association with the Fear of Hypoglycemia among the Parents of Children with Type 1 Diabetes.
    Muradoğlu S; Yeşiltepe Mutlu G; Gökçe T; Can E; Hatun Ş
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):285-292. PubMed ID: 33491925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel lyophilized hydrogel patches for convenient and effective administration of microneedle-mediated insulin delivery.
    Qiu Y; Qin G; Zhang S; Wu Y; Xu B; Gao Y
    Int J Pharm; 2012 Nov; 437(1-2):51-6. PubMed ID: 22842625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
    Hövelmann U; Bysted BV; Mouritzen U; Macchi F; Lamers D; Kronshage B; Møller DV; Heise T
    Diabetes Care; 2018 Mar; 41(3):531-537. PubMed ID: 29273578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.
    Pontiroli AE
    J Diabetes Sci Technol; 2015 Jan; 9(1):38-43. PubMed ID: 25385946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microneedle Patches Loaded with Nanovesicles for Glucose Transporter-Mediated Insulin Delivery.
    Chen Q; Xiao Z; Wang C; Chen G; Zhang Y; Zhang X; Han X; Wang J; Ye X; Prausnitz MR; Li S; Gu Z
    ACS Nano; 2022 Nov; 16(11):18223-18231. PubMed ID: 36322923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study.
    Ranjan A; Schmidt S; Damm-Frydenberg C; Steineck I; Clausen TR; Holst JJ; Madsbad S; Nørgaard K
    Diabetes Care; 2017 Jan; 40(1):132-135. PubMed ID: 27797928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia.
    Li NX; Brown S; Kowalski T; Wu M; Yang L; Dai G; Petrov A; Ding Y; Dlugos T; Wood HB; Wang L; Erion M; Sherwin R; Kelley DE
    Diabetes; 2018 Jul; 67(7):1401-1413. PubMed ID: 29669745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The New Wave.
    Neithercott T
    Diabetes Forecast; 2016; 69(2):42-5. PubMed ID: 27048047
    [No Abstract]   [Full Text] [Related]  

  • 38. Assisted 3D printing of microneedle patches for minimally invasive glucose control in diabetes.
    Wu M; Zhang Y; Huang H; Li J; Liu H; Guo Z; Xue L; Liu S; Lei Y
    Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111299. PubMed ID: 32919660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
    Pontiroli AE; Ceriani V
    Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
    Stenninger E; Aman J
    Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.